Clinical Decision Support Should Strengthen a Pharmacist's Judgment

AI clinical decision support should give a pharmacist a clearer basis for professional judgment. The important question is what the reviewer can see and control: the information behind a suggestion, the limits of that information, the ability to change the output and the record of the final decision. A polished explanation is only useful when those parts of the workflow are inspectable.

Set the standard before evaluating features

Our view is that a pharmacy should define the role of decision support before comparing products. Specify the task it is meant to assist, the person who will review its output and the information that person needs. A tool used to organize a record raises different questions from a tool making a resident-specific recommendation.

The FDA's January 2026 clinical decision support guidance discusses independent review of the basis for recommendations as one criterion for certain software functions excluded from the device definition. That principle is a useful reference for evaluation; it does not, by itself, establish the regulatory status of any particular product.

Make the basis of a suggestion available

Ask to open the material supporting a suggested concern. The reviewer should be able to identify the resident, the relevant record and the information the software used. A link to a general reference and a link to the resident's source document answer different questions. Both may matter to understanding an output.

Consider a demonstration where two documents have different dates. Ask which one informed the suggestion and how the product handled the other. This is a useful way to see whether the interface exposes its assumptions. The evaluator can then judge the explanation against the records, rather than accepting the explanation as its own evidence.

Show uncertainty where the decision happens

Put missing information in the reviewer's line of sight. If the available material does not establish whether an order is current, the output should leave that question visible. A blank field, an unreadable value and a confirmed absence deserve different treatment in the interface.

This is a product-design standard a team can test. Use a fictional example with one deliberately incomplete record. Ask what the reviewer sees, what can be clarified and whether the final document preserves the limitation. The goal is to understand the boundary of the result, including what the tool could not determine.

Let the pharmacist author the decision

Accepting, editing and declining a suggestion should be ordinary review actions. Each should lead to a clear state, with language that reflects what the pharmacist actually decided. A reviewer who needs more context should also have a way to leave a question pending.

Pay attention to the exported document. Does an edit appear in the final wording? Is a declined suggestion kept out of the active recommendation? Can another authorized team member distinguish generated material from the pharmacist's completed work? Those are more useful observations than a demonstration that ends at the first alert.

Treat correction as part of normal work

Correction deserves a defined path. Ask how a user reports a mismatched document, an incorrect interpretation or a confusing output, and how the issue is tracked. Establish who in the practice follows the report and how the team learns that a correction is available.

Do not assume that rejecting a suggestion retrains a model or changes future behavior. Have the vendor explain what feedback changes, who reviews it and how updates are communicated. A visible feedback process is something an organization can evaluate without making assumptions about the technology underneath.

Apply the same clarity to product availability

A capability demonstrated today, a limited trial and a planned feature provide different kinds of evidence. Ask for the availability of each workflow you intend to use, including the parts after review: documentation, delivery, response handling and later retrieval.

Bring these standards into any vendor conversation, including one with Pharmacore. Choose a representative task and ask to follow it from source information to the pharmacist's final wording. Book a product conversation with that task in mind, and record what the demonstration establishes.